Editor’s note: Related tickers: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), iShares Russell 2000 Index (ETF) (NYSEARCA:IWM), Brightcove Inc (NASDAQ:BCOV), Allergan, Inc. (NYSE:AGN), Smith & Wesson Holding Corporation (NASDAQ:SWHC)
A good way to follow stocks is by tracking the most trended stocks on the stocktwits.com website. Among these stocks we can mention: Regeneron Pharmaceuticals Inc (NASDAQ:REGN), iShares Russell 2000 Index (ETF) (NYSEARCA:IWM), Brightcove Inc (NASDAQ:BCOV), Allergan, Inc. (NYSE:AGN), Smith & Wesson Holding Corporation (NASDAQ:SWHC).
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is trading 13.64% higher at $244.49. According to a proxy filing with the Securities and Exchange Commission, Leonard S. Schleifer, president and CEO of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned about $30 million in 2012, which is almost three times more than a year before. At the same time, the Chief Scientific Officer and president, George D. Yancopoulos received even more, about $81.5 million, which, compared to 2011 earnings of $10 million, represents an increase by about 8 times. “Our common stock was the top performing NASDAQ stock for a company with a market capitalization greater than $5 billion over the past one- and three-year periods, and the top performing stock among our Peer Group over the past one-, three- and five-year periods,” Regeneron Pharmaceuticals Inc (NASDAQ:REGN) also said in the filing.
The ETF iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) has also made the list. Currently iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) is trading 2.15% lower at $92.11. According to Reuters, iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) looks for investment results that usually agree to the price and yield of the Russell 2000 Index, which comprises about 8% of the market capitalization of all publicly traded U.S. equity securities.
Brightcove Inc (NASDAQ:BCOV) jumped by 27.91% to $7.70 amid positive financial results. Total revenue of Brightcove Inc (NASDAQ:BCOV) in the first quarter of 2013 totalled $24.7 million, which represents a 24% increased compared to the previous year. Brightcove Inc (NASDAQ:BCOV) also posted a $16.3 million gross profit in the first quarter of 2013, against $13.6 million a year ago, the company said in a statement. It added that Brightcove Inc (NASDAQ:BCOV) expects revenue between $25.7 million and $26.2 million for the second quarter of 2013, while for the whole 2013, it estimates revenue to amount to $104 million to $106 million.
Allergan, Inc. (NYSE:AGN) is the next on our list showing a 12.51% decline to $99.15. According to a statement issued today, Allergan, Inc. (NYSE:AGN) posted $0.89 diluted EPS, compared to $0.74 a year ago. The sales of the company increased by an annual 8.4% to $1.4 billion. At the same time, Allergan, Inc. (NYSE:AGN) expects sales between $5.98 billion and $6.20 billion over the whole 2013, while for the second quarter the sales are estimated at between $1.5 billion and $1.58 billion. The statement added that Allergan, Inc. (NYSE:AGN)’s Board of Directors announced a first quarter dividend amounting to $0.05 per share.
Smith & Wesson Holding Corporation (NASDAQ:SWHC) declined by 2.37% to $8.57. According to our database, 25 hedge funds held Smith & Wesson Holding Corporation (NASDAQ:SWHC) in their equity portfolio.
Disclosure: none
